Melas Theo Kyriazi's most recent trade in Evelo Biosciences Inc was a trade of 20,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 8, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Evelo Biosciences Inc | Melas Theo Kyriazi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
Evelo Biosciences Inc | Melas Theo Kyriazi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
Evelo Biosciences Inc | Melas Theo Kyriazi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 15,690 | 15,690 | - | - | Stock Option (Right to Buy) | |
Evelo Biosciences Inc | Melas Theo Kyriazi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 1,810 | 1,810 | - | - | Stock Option (Right to Buy) | |
Evelo Biosciences Inc | Melas Theo Kyriazi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2020 | 15,690 | 15,690 | - | - | Stock Option (Right to Buy) |